During the past decade, Antalya Training and Research Hospital conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 5 clinical trials were completed, i.e. on average, 13.9% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 3 clinical trials were completed. i.e. 12% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Antalya Training and Research Hospital" #1 sponsor was "Antalya Training and Research Hospital" with 22 trials, followed by "Pfizer" with 4 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "Diskapi Teaching and Research Hospital" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Antalya Training and Research Hospital" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Turkish Society of Anesthesiology and Reanimation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Antalya Training and Research Hospital" are "Pain" (3 trials), "Ulcerative Colitis" (3 trials), "Blood Transfusion" (2 trials), "Bupivacaine" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Antalya Training and Research Hospital" in a lesser frequency.

Most popular intervention types in "Antalya Training and Research Hospital" are "Other" (18 trials), "Drug" (10 trials), "Device" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Etrasimod" (4 trials), "Blood transfusion" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "minimum effective volume" (2 trials). Other intervention names were less common.

The vast majority of trials in "Antalya Training and Research Hospital" are 33 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Antalya Training and Research Hospital". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Antalya Training and Research Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Antalya Training and Research Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".